The pharmaceutical landscape is witnessing a shift with the emergence of GLP-1 transdermal systems . These exciting formulations offer a potential alternative to administering glucagon-like peptide-1 https://anyatipy900303.theideasblog.com/41411952/glp-1-patches-a-revolutionary-way-to-control-diabetes